Pharvaris N.V.(PHVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PHVS Pharvaris N.V.

Market Closed 04-26 16:00:00 EDT

23.35

+0.58

+2.55%

盘后23.35

+0.000.00%

16:03 EDT

High25.44	Low22.20	Vol84.97K
Open22.56	D1 Closing22.77	Amplitude14.23%
Mkt Cap1.26B	Tradable Cap514.24M	Total Shares53.82M
T/O2.05M	T/O Rate0.39%	Tradable Shares22.02M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":23.35,"timestamp":1714161600000,"preClose":22.77,"halted":0,"volume":84967,"hourTrading":{"tag":"盘后","latestPrice":23.35,"preClose":23.35,"latestTime":"16:03 EDT","volume":369,"amount":8716.15,"timestamp":1714161813553},"delay":0,"floatShares":22023335,"shares":53816707,"eps":-2.904305,"marketStatus":"Market Closed","change":0.58,"latestTime":"04-26 16:00:00 EDT","open":22.56,"high":25.44,"low":22.2,"amount":2045394.7644,"amplitude":0.142292,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.904305,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1714377600000},"marketStatusCode":7,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":22.77,"postHourTrading":{"tag":"盘后","latestPrice":23.35,"preClose":23.35,"latestTime":"16:03 EDT","volume":369,"amount":8716.15,"timestamp":1714161813553},"volumeRatio":1.0901311234225788},"requestUrl":"/m/hq/s/PHVS","defaultTab":"news","newsList":[{"id":"2426678631","title":"Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2426678631","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2426678631?lang=en_us&edition=fundamental","pubTime":"2024-04-12 19:54","pubTimestamp":1712922847,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. Indeed, Pharvaris  stock is up 162% in the last year, providing strong gains for shareholders. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.In light of its strong share price run, we think now is a good time to investigate how risky Pharvaris' cash burn is. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth . The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.Pharvaris' cash burn of 93m is about 8.3% of its 1.1b market capitalisation. That's a low proportion, so we figure the company would be able to raise more cash to","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharvaris-nasdaq-phvs-good-position-115407995.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426227639","title":"Buy Rating Affirmed for Pharvaris on Strong HAE Drug Potential and Solid Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2426227639","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426227639?lang=en_us&edition=fundamental","pubTime":"2024-04-12 13:39","pubTimestamp":1712900394,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on PHVS stock, giving a Buy rating yesterday. Joseph Schwartz has give...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-pharvaris-on-strong-hae-drug-potential-and-solid-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-pharvaris-on-strong-hae-drug-potential-and-solid-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426233908","title":"Pharvaris Excels in HAE Treatment Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2426233908","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426233908?lang=en_us&edition=fundamental","pubTime":"2024-04-11 16:40","pubTimestamp":1712824827,"startTime":"0","endTime":"0","summary":"Pharvaris N.V. (PHVS) has released an update. Pharvaris N.V., a late-stage biopharmaceutical company, has reported strong financial results for 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-excels-in-hae-treatment-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-excels-in-hae-treatment-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2420229907","title":"Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Alpine Immune Sciences (ALPN) and IGM Biosciences (IGMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2420229907","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2420229907?lang=en_us&edition=fundamental","pubTime":"2024-03-19 20:50","pubTimestamp":1710852635,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharvaris (PHVS – Research Report), Alpine Immune Sc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-alpine-immune-sciences-alpn-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-alpine-immune-sciences-alpn-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharvaris.com","stockEarnings":[{"period":"1week","weight":0.2187},{"period":"1month","weight":-0.0064},{"period":"3month","weight":-0.2201},{"period":"6month","weight":0.3177},{"period":"1year","weight":1.5916},{"period":"ytd","weight":-0.1676}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.020178},{"month":2,"riseRate":0,"avgChangeRate":-0.112856},{"month":3,"riseRate":0.5,"avgChangeRate":-0.050124},{"month":4,"riseRate":0.5,"avgChangeRate":-0.006294},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.058884},{"month":6,"riseRate":0.666667,"avgChangeRate":0.299144},{"month":7,"riseRate":0.333333,"avgChangeRate":0.021717},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.080606},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.08667},{"month":10,"riseRate":0,"avgChangeRate":-0.198539},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.230177},{"month":12,"riseRate":0.666667,"avgChangeRate":1.646622}],"exchange":"NASDAQ","name":"Pharvaris N.V.","nameEN":"Pharvaris N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharvaris N.V.(PHVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharvaris N.V.(PHVS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharvaris N.V.,PHVS,Pharvaris N.V.股票,Pharvaris N.V.股票老虎,Pharvaris N.V.股票老虎国际,Pharvaris N.V.行情,Pharvaris N.V.股票行情,Pharvaris N.V.股价,Pharvaris N.V.股市,Pharvaris N.V.股票价格,Pharvaris N.V.股票交易,Pharvaris N.V.股票购买,Pharvaris N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharvaris N.V.(PHVS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharvaris N.V.(PHVS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction